BBIO Stock Analysis: Buy, Sell, or Hold?
BBIO - BridgeBio Pharma, Inc. Common Stock
$77.27
-1.83 (-2.31%)
▼
5d:
-0.77%
30d:
+2.37%
90d:
+15.99%
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 19, 2026
16d
Get Alerted When BBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BBIO shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: BBIO shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: BBIO is currently trading at $77.27, which is considered fair relative to its 30-day fair value range of $75.21 to $78.42.
Technical Outlook: Technically, BBIO is in a strong uptrend. Immediate support is located at $73.77, while resistance sits at $81.33.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $93.15 (+20.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BBIO is in a strong uptrend. Immediate support is located at $73.77, while resistance sits at $81.33.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $93.15 (+20.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$75.21 -
$78.42
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 20.6% below Wall St target ($93.15)
Fair Price Analysis
30-Day Fair Range
$75.21 -
$78.42
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$73.77
Resistance Level
$81.33
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-43.57
Wall Street Target
$93.15
(+20.6%)
Revenue Growth (YoY)
4318.0%
Profit Margin
-225.3%
Last updated: February 01, 2026 11:19 PM ET
Data refreshes hourly during market hours. Next update: 12:19 AM
Data refreshes hourly during market hours. Next update: 12:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BBIO showing a specific setup today?
Insider Activity (6 Months)
2
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Neil Kumar
SELL
40000 shares
2025-10-08
Gilbert Ray Cisneros, Jr.
BUY
2025-09-22
Frank Mccormick
SELL
74000 shares
2025-09-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$89 | 61 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$213 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
Advanced BBIO Option Strategies
Professional options setups generated by AI based on today's BBIO price and gamma walls.
